Improvement of erythropoiesis during treatment with deferiprone in a patient with myelofibrosis and transfusional hemosiderosis
β Scribed by Smeets, M.E.P.; Vreugdenhil, G.; Holdrinet, R.S.G.
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 233 KB
- Volume
- 51
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Reactive systemic AA amyloidosis is a severe complication of rheumatoid arthritis (RA), occurring in 2-5% of RA patients (1). Infliximab, a monoclonal antibody against tumor necrosis factor β£ (TNFβ£), is successfully used in the treatment of RA (2). TNFβ£ plays a key role in inducing the synthesis of
roradiological features beyond the typical cerebellar peduncle hyperintensities that were found minimal in this instance. FXTAS is expected to be less severe in females because of the presence of two X chromosomes, subject to random inactivation. It has been suggested that expression of the disease
## Abstract ## Objective This study was conducted to determine the effect of olanzapine treatment on cognition in elderly patients with behavioral and psychiatric symptoms (BPSD) associated with dementia. ## Methods This was a postβhoc analysis of three randomized doubleβblind, clinical trials o